Intraocular inflammation after proton beam irradiation for uveal melanoma. 2001

L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
Department of Ophthalmology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France.

OBJECTIVE To describe the inflammatory reaction that can occur following proton beam irradiation of uveal melanomas based on a large series of patients and to try to determine the risk factors for this reaction. METHODS Data from a cohort of patients with uveal melanoma treated by proton beam irradiation between 1991 and 1994 were analysed. The presence of inflammation was recorded and evaluated. Kaplan-Meier estimates and statistical analysis of general and tumour related risk factors were performed. RESULTS 28% of patients treated during this period presented with ocular inflammation (median follow up 62 months). Risks factors were essentially tumour related and were correlated with larger lesions (height > 5 mm, diameter > 12 mm, volume > 0.4 cm(3)). Multivariate analysis identified initial tumour height and irradiation of a large volume of the eye as the two most important risk factors. Ocular inflammation usually consisted of mild anterior uveitis, resolving rapidly after topical steroids and cycloplegics. The incidence of inflammation after proton beam irradiation of melanomas seems higher than previously reported and is related to larger lesions. Evidence of inflammation associated with uveal melanoma has been described and seems to be associated with tumour necrosis (spontaneous or after irradiation). The appearance of transient inflammation during the follow up of these patients may be related to the release of inflammatory cytokines during tumour necrosis. CONCLUSIONS Inflammation following proton beam irradiation is not unusual. It is correlated with larger initial tumours and may be related to tumour necrosis.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009184 Mydriatics Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. Cycloplegic,Cycloplegics,Mydriatic,Mydriatic Effect,Mydriatic Effects,Effect, Mydriatic,Effects, Mydriatic
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
May 1992, Ophthalmology,
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
March 2005, Ophthalmology clinics of North America,
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
February 1995, American journal of ophthalmology,
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
July 1988, Ophthalmology,
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
May 1986, Ophthalmology,
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
August 2000, Archives of ophthalmology (Chicago, Ill. : 1960),
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
September 1989, Ophthalmology,
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
October 2017, Journal of cataract and refractive surgery,
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
January 2016, Klinika oczna,
L Lumbroso, and L Desjardins, and C Levy, and C Plancher, and E Frau, and F D'Hermies, and P Schlienger, and H Mammar, and S Delacroix, and C Nauraye, and R Ferrand, and C Desblancs, and A Mazal, and B Asselain
January 1989, Ophthalmology,
Copied contents to your clipboard!